[SCHEDULE 13G/A] ReShape Lifesciences, Inc. SEC Filing
ReShape Lifesciences Schedule 13G/A filed by CVI Investments, Inc. and Heights Capital Management, Inc. reports that the reporting persons beneficially own 0 shares (0%) of the company鈥檚 common stock. Heights Capital is identified as the investment manager to CVI and may be deemed to have voting and dispositive power over shares held by CVI, although both entities expressly disclaim beneficial ownership except for any pecuniary interest. The filing notes ownership is below 5% and certifies the securities were not acquired to change or influence control of the issuer.
ReShape Lifesciences Il Schedule 13G/A depositato da CVI Investments, Inc. e Heights Capital Management, Inc. indica che i soggetti segnalanti non detengono 0 azioni (0%) del capitale ordinario della societ脿. Heights Capital 猫 identificata come gestore degli investimenti di CVI e potrebbe essere considerata titolare del potere di voto e di disposizione sulle azioni detenute da CVI, pur precisando che entrambe le entit脿 dichiarano espressamente di non vantare la qualit脿 di beneficiario, fatta eccezione per eventuali interessi pecuniari. Il deposito segnala che la partecipazione 猫 inferiore al 5% e certifica che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente.
ReShape Lifesciences El Schedule 13G/A presentado por CVI Investments, Inc. y Heights Capital Management, Inc. indica que las personas informantes no poseen 0 acciones (0%) del capital social ordinario de la compa帽铆a. Heights Capital figura como gestor de inversiones de CVI y podr铆a considerarse que tiene poder de voto y de disposici贸n sobre las acciones en poder de CVI, aunque ambas entidades declaran expresamente que no reclaman la condici贸n de propietarios beneficiarios, salvo por cualquier inter茅s pecuniario. La presentaci贸n se帽ala que la participaci贸n es inferior al 5% y certifica que los valores no se adquirieron para cambiar o influir en el control del emisor.
ReShape Lifesciences CVI Investments, Inc.鞕� Heights Capital Management, Inc.臧� 鞝滌稖頃� Schedule 13G/A鞐� 霐半ゴ氅� 氤搓碃 欤检泊霌れ潃 須岇偓鞚� 氤错喌欤茧ゼ 0欤�(0%) 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 氤搓碃霅橃棃鞀惦媹雼�. Heights Capital鞚� CVI鞚� 韴瀽鞖挫毄靷 歆�鞝曤悩鞏� 鞛堨溂氅� CVI臧� 氤挫湢頃� 欤检嫕鞐� 雽�頃� 鞚橁舶甓� 氚� 觳橂秳甓岇潉 臧�歆� 瓴冹溂搿� 臧勳＜霅� 靾� 鞛堨溂雮�, 鞏戩偓電� 旮堨爠鞝� 鞚挫澋鞚� 鞝滌櫢頃橁碃 鞁れ鞝� 靻岇湢甓岇潉 欤检灔頃橃 鞎婋姅雼り碃 氇呾嫓鞝侅溂搿� 攵�鞚疙暕雼堧嫟. 鞝滌稖靹滊電� 氤挫湢 牍勳鞚� 5% 氙鸽鞛勳潉 旮办灛頃橁碃, 頃措嫻 歃濌秾鞚� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃╇媹雼�.
ReShape Lifesciences Le Schedule 13G/A d茅pos茅 par CVI Investments, Inc. et Heights Capital Management, Inc. indique que les personnes d茅clarante ne d茅tiennent pas 0 actions (0%) des actions ordinaires de la soci茅t茅. Heights Capital est d茅sign茅 comme gestionnaire d'investissement de CVI et peut 锚tre consid茅r茅 comme ayant le pouvoir de vote et de disposition sur les actions d茅tenues par CVI, bien que les deux entit茅s d茅clinent express茅ment toute qualit茅 de propri茅taire b茅n茅ficiaire, 脿 l'exception de tout int茅r锚t p茅cuniaire. Le d茅p么t pr茅cise que la participation est inf茅rieure 脿 5% et certifie que les titres n'ont pas 茅t茅 acquis dans le but de changer ou d'influencer le contr么le de l'茅metteur.
ReShape Lifesciences Die von CVI Investments, Inc. und Heights Capital Management, Inc. eingereichte Schedule 13G/A meldet, dass die meldenden Personen 0 Aktien (0%) der Stammaktien des Unternehmens besitzen. Heights Capital wird als Investmentmanager von CVI bezeichnet und k枚nnte hinsichtlich der von CVI gehaltenen Aktien als stimmberechtigt und verf眉gungsbefugt angesehen werden, obwohl beide Gesellschaften ausdr眉cklich erkl盲ren, keine wirtschaftliche Eigent眉merschaft geltend zu machen, abgesehen von etwaigen finanziellen Interessen. Die Einreichung weist darauf hin, dass die Beteiligung unter 5% liegt, und best盲tigt, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
- Clear ownership disclosure: Reporting Persons state 0 shares (0%) beneficial ownership of ReShape Lifesciences common stock.
- Manager relationship disclosed: Heights Capital Management is identified as investment manager to CVI and the filing discloses potential voting/dispositive power while disclaiming beneficial ownership.
- No control intent: The certification affirms the securities were not acquired to change or influence control of the issuer.
- None.
Insights
TL;DR: Reporting persons disclose no economic stake in RSLS; the filing is informational and not materially impactful.
The Schedule 13G/A confirms 0 shares (0%) beneficial ownership by CVI Investments and Heights Capital in ReShape Lifesciences. For market and valuation purposes, a zero ownership disclosure carries no immediate capital-market implications. The filing does, however, disclose the manager-client relationship whereby Heights Capital may exercise voting or dispositive power over CVI-held shares while disclaiming beneficial ownership except for pecuniary interest. Overall this is a routine, non-material disclosure.
TL;DR: Filing clarifies potential voting/dispositive authority via an investment manager but affirms no beneficial ownership or control intent.
The document explicitly records that Heights Capital Management serves as investment manager to CVI Investments and may be deemed to have voting and dispositive power with respect to CVI鈥檚 holdings, yet both reporting persons disclaim beneficial ownership other than any pecuniary interest. The certification paragraph states the securities were not acquired to influence control. From a governance perspective this filing provides transparency about relationships and confirms no control-seeking activity.
ReShape Lifesciences Il Schedule 13G/A depositato da CVI Investments, Inc. e Heights Capital Management, Inc. indica che i soggetti segnalanti non detengono 0 azioni (0%) del capitale ordinario della societ脿. Heights Capital 猫 identificata come gestore degli investimenti di CVI e potrebbe essere considerata titolare del potere di voto e di disposizione sulle azioni detenute da CVI, pur precisando che entrambe le entit脿 dichiarano espressamente di non vantare la qualit脿 di beneficiario, fatta eccezione per eventuali interessi pecuniari. Il deposito segnala che la partecipazione 猫 inferiore al 5% e certifica che i titoli non sono stati acquisiti per modificare o influenzare il controllo dell'emittente.
ReShape Lifesciences El Schedule 13G/A presentado por CVI Investments, Inc. y Heights Capital Management, Inc. indica que las personas informantes no poseen 0 acciones (0%) del capital social ordinario de la compa帽铆a. Heights Capital figura como gestor de inversiones de CVI y podr铆a considerarse que tiene poder de voto y de disposici贸n sobre las acciones en poder de CVI, aunque ambas entidades declaran expresamente que no reclaman la condici贸n de propietarios beneficiarios, salvo por cualquier inter茅s pecuniario. La presentaci贸n se帽ala que la participaci贸n es inferior al 5% y certifica que los valores no se adquirieron para cambiar o influir en el control del emisor.
ReShape Lifesciences CVI Investments, Inc.鞕� Heights Capital Management, Inc.臧� 鞝滌稖頃� Schedule 13G/A鞐� 霐半ゴ氅� 氤搓碃 欤检泊霌れ潃 須岇偓鞚� 氤错喌欤茧ゼ 0欤�(0%) 氤挫湢頃橁碃 鞛堧姅 瓴冹溂搿� 氤搓碃霅橃棃鞀惦媹雼�. Heights Capital鞚� CVI鞚� 韴瀽鞖挫毄靷 歆�鞝曤悩鞏� 鞛堨溂氅� CVI臧� 氤挫湢頃� 欤检嫕鞐� 雽�頃� 鞚橁舶甓� 氚� 觳橂秳甓岇潉 臧�歆� 瓴冹溂搿� 臧勳＜霅� 靾� 鞛堨溂雮�, 鞏戩偓電� 旮堨爠鞝� 鞚挫澋鞚� 鞝滌櫢頃橁碃 鞁れ鞝� 靻岇湢甓岇潉 欤检灔頃橃 鞎婋姅雼り碃 氇呾嫓鞝侅溂搿� 攵�鞚疙暕雼堧嫟. 鞝滌稖靹滊電� 氤挫湢 牍勳鞚� 5% 氙鸽鞛勳潉 旮办灛頃橁碃, 頃措嫻 歃濌秾鞚� 氚滍枆鞚胳潣 歆�氚瓣秾鞚� 氤�瓴巾晿瓯半倶 鞓來枼鞚� 氙胳箻旮� 鞙勴暣 旆摑霅� 瓴冹澊 鞎勲嫎鞚� 鞚胳頃╇媹雼�.
ReShape Lifesciences Le Schedule 13G/A d茅pos茅 par CVI Investments, Inc. et Heights Capital Management, Inc. indique que les personnes d茅clarante ne d茅tiennent pas 0 actions (0%) des actions ordinaires de la soci茅t茅. Heights Capital est d茅sign茅 comme gestionnaire d'investissement de CVI et peut 锚tre consid茅r茅 comme ayant le pouvoir de vote et de disposition sur les actions d茅tenues par CVI, bien que les deux entit茅s d茅clinent express茅ment toute qualit茅 de propri茅taire b茅n茅ficiaire, 脿 l'exception de tout int茅r锚t p茅cuniaire. Le d茅p么t pr茅cise que la participation est inf茅rieure 脿 5% et certifie que les titres n'ont pas 茅t茅 acquis dans le but de changer ou d'influencer le contr么le de l'茅metteur.
ReShape Lifesciences Die von CVI Investments, Inc. und Heights Capital Management, Inc. eingereichte Schedule 13G/A meldet, dass die meldenden Personen 0 Aktien (0%) der Stammaktien des Unternehmens besitzen. Heights Capital wird als Investmentmanager von CVI bezeichnet und k枚nnte hinsichtlich der von CVI gehaltenen Aktien als stimmberechtigt und verf眉gungsbefugt angesehen werden, obwohl beide Gesellschaften ausdr眉cklich erkl盲ren, keine wirtschaftliche Eigent眉merschaft geltend zu machen, abgesehen von etwaigen finanziellen Interessen. Die Einreichung weist darauf hin, dass die Beteiligung unter 5% liegt, und best盲tigt, dass die Wertpapiere nicht erworben wurden, um die Kontrolle des Emittenten zu 盲ndern oder zu beeinflussen.
FAQ
Who filed the Schedule 13G/A for ReShape Lifesciences (RSLS)?
How many RSLS shares do the reporting persons own?
Does Heights Capital have voting or dispositive power over RSLS shares?
Is the reported ownership above 5% of RSLS?
Does the filing indicate an intent to influence control of ReShape Lifesciences?
